Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy)

Michael H. Olsen; Kristian Wachtell; Jonathan N. Bella; Jennifer E. Liu; Kurt Boman; Eva Gerdts; Vasilios Papademetriou; Markku S. Nieminen; Jens Rokkedal; Björn Dahlöf; Richard B. Devereux

doi:10.1016/j.amjcard.2004.06.074

Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy)

Michael H. Olsen
, Kristian Wachtell
, Jonathan N. Bella
, Jennifer E. Liu
, Kurt Boman
, Eva Gerdts
, Vasilios Papademetriou
, Markku S. Nieminen
, Jens Rokkedal
, Björn Dahlöf
, Richard B. Devereux

Research output: Contribution to journal › Article › peer-review

28 Scopus citations

Abstract

Neither losartan- nor atenolol-based antihypertensive regimens could prevent the progression of aortic valve (AV) sclerosis in elderly, high-risk hypertensive patients, and the regression of AV sclerosis did not translate into reduced cardiovascular risk.

Original language	English
Pages (from-to)	1076-1080
Number of pages	5
Journal	American Journal of Cardiology
Volume	94
Issue number	8
DOIs	https://doi.org/10.1016/j.amjcard.2004.06.074
State	Published - 15 Oct 2004
Externally published	Yes

Access to Document

10.1016/j.amjcard.2004.06.074

Cite this

@article{0f5dd1bf536f4326be003b64e0132b28,

title = "Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy)",

abstract = "Neither losartan- nor atenolol-based antihypertensive regimens could prevent the progression of aortic valve (AV) sclerosis in elderly, high-risk hypertensive patients, and the regression of AV sclerosis did not translate into reduced cardiovascular risk.",

author = "Olsen, \{Michael H.\} and Kristian Wachtell and Bella, \{Jonathan N.\} and Liu, \{Jennifer E.\} and Kurt Boman and Eva Gerdts and Vasilios Papademetriou and Nieminen, \{Markku S.\} and Jens Rokkedal and Bj{\"o}rn Dahl{\"o}f and Devereux, \{Richard B.\}",

note = "Funding Information: This study was supported in part by grants from Merck \& Co., Inc., West Point, Pennsylvania. ",

year = "2004",

month = oct,

day = "15",

doi = "10.1016/j.amjcard.2004.06.074",

language = "English",

volume = "94",

pages = "1076--1080",

journal = "American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "8",

}

TY - JOUR

T1 - Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy)

AU - Olsen, Michael H.

AU - Wachtell, Kristian

AU - Bella, Jonathan N.

AU - Liu, Jennifer E.

AU - Boman, Kurt

AU - Gerdts, Eva

AU - Papademetriou, Vasilios

AU - Nieminen, Markku S.

AU - Rokkedal, Jens

AU - Dahlöf, Björn

AU - Devereux, Richard B.

N1 - Funding Information: This study was supported in part by grants from Merck & Co., Inc., West Point, Pennsylvania.

PY - 2004/10/15

Y1 - 2004/10/15

N2 - Neither losartan- nor atenolol-based antihypertensive regimens could prevent the progression of aortic valve (AV) sclerosis in elderly, high-risk hypertensive patients, and the regression of AV sclerosis did not translate into reduced cardiovascular risk.

AB - Neither losartan- nor atenolol-based antihypertensive regimens could prevent the progression of aortic valve (AV) sclerosis in elderly, high-risk hypertensive patients, and the regression of AV sclerosis did not translate into reduced cardiovascular risk.

UR - https://www.scopus.com/pages/publications/5044238644

U2 - 10.1016/j.amjcard.2004.06.074

DO - 10.1016/j.amjcard.2004.06.074

M3 - Article

C2 - 15476632

AN - SCOPUS:5044238644

SN - 0002-9149

VL - 94

SP - 1076

EP - 1080

JO - American Journal of Cardiology

JF - American Journal of Cardiology

IS - 8

ER -

Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy)

Abstract

Access to Document

Fingerprint

Cite this